Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.

Yang Yang, PhD, of Purdue University is the recipient of a major 5-year grant for Personalized Treatment Development in SCN2A-Related Disorders

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

LifeBank Chain (LBC) focuses on genetics and cell research, with the purposes of furthering human longevity and expanding access to genetics and cell treatments.

Three prizes of $50,000 will be awarded to early-career immigrant research scientists

From Cultural Curiosity to Health Necessity in COVID

Asia Pacific genome editing market will showcase growth of 15% during the forecast period owing to increasing number of genetic research organizations in emerging economies that are working on the development of innovative gene-editing tools.

BillionToOne and Eluthia have announced today the launch of the first and only non-invasive prenatal test, allowing to screen for the autosomal-recessive conditions cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease and other hemoglobinopathies. The UNITY™ screen will be made available through Eluthia in Germany, Austria, Switzerland, and the Netherlands, as of now.

The Virtual Center for Velo-Cardio-Facial Syndrome collaborates with the Center for Precision Neuropsychiatry based in the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons

Dante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy.

Partnership offers PGx solutions on advanced genotyping array to enable precision medicine

The Color-Sayre partnership will provide a fully integrated solution for patients and providers by delivering actionable clinical test results at an accessible price point.

Dante Labs introduced a new Whole Genome Sequencing of 130X coverage for the Exome and 30X coverage for DNA's non-coding regions

Promotional offer: Free Xcode Ancestry report for all eligible individuals

CAP Accreditation is Awarded to Clinical Laboratories Meeting the Highest Standards in Quality Laboratory Practices

Partnership combines local support with global capabilities to deliver affordable tests to identify genetic mutations associated with an increased risk for hereditary cancer and inherited heart conditions for which early knowledge can make a difference.

Two U.S. BioTechs partner to unlock more data discovery in genomics, creating first end-to-end analysis engine simplified for researchers

Comprehensive Interrogation of the Genetic Determinants of Female and Male Infertility: A New NGS Research Application Enabled by Improvements in Target Enrichment Technology

Anonymous donor presents $1 million gift to The Ehlers-Danlos Society to jumpstart groundbreaking genomic research into genetic cause of hypermobile Ehlers-Danlos syndrome (hEDS), a rare, degenerative, and all-too-often painful, disabling connective tissue disorder

DNA industry experts help consumers make best decision this holiday season with unbiased analysis of the leading DNA test companies

Strand NGS now supports large scale RNA- and small-RNA-Seq and Unique Molecular Identifiers (UMIs) for DNA-, RNA-, and small-RNA-Seq.

Announced by ingenious targeting laboratory

BABYGlimpse, a new app available on the Helix marketplace, explores over 20 different traits, including ancestry, physical appearance, and wellness-related traits

Bringing mental health professionals and genetic scientists together.

Baylor Genetics Partners With Rainbow Genomics

Discovery at Gladstone Institutes will help reevaluate the cause of certain cancers and developmental defects